Posted

0 replies · 1 reposts · 1 likes

The SAIVE Trial examined ivermectin following exposure to SARS-CoV-2 and reported a 71.57% relative risk reduction in the study population. The results add to ongoing scientific discussion and should be interpreted within the broader evidence base. #IvermectinResearch #COVID19 #ClinicalTrial #ResearchFindings #MedicalScience #HealthResearch

View this post on Gab